BSF Enterprise PLC is a United Kingdom-based biotech company... Show more
The Aroon Indicator for BSFAF entered a downward trend on June 18, 2025. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 36 similar instances where the Aroon Indicator formed such a pattern. In of the 36 cases the stock moved lower. This puts the odds of a downward move at .
BSFAF moved below its 50-day moving average on June 23, 2025 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for BSFAF crossed bearishly below the 50-day moving average on June 23, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 4 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence (MACD) for BSFAF just turned positive on June 24, 2025. Looking at past instances where BSFAF's MACD turned positive, the stock continued to rise in of 6 cases over the following month. The odds of a continued upward trend are .
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BSFAF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.093) is normal, around the industry mean (16.366). P/E Ratio (0.000) is within average values for comparable stocks, (58.189). BSFAF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.309). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (116.279) is also within normal values, averaging (252.247).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BSFAF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
Industry Biotechnology
A.I.dvisor indicates that over the last year, BSFAF has been loosely correlated with YECO. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if BSFAF jumps, then YECO could also see price increases.
Ticker / NAME | Correlation To BSFAF | 1D Price Change % | ||
---|---|---|---|---|
BSFAF | 100% | N/A | ||
YECO - BSFAF | 50% Loosely correlated | N/A | ||
IMMP - BSFAF | 29% Poorly correlated | N/A | ||
GLUE - BSFAF | 24% Poorly correlated | -1.29% | ||
HNSBF - BSFAF | 21% Poorly correlated | N/A | ||
BLRX - BSFAF | 21% Poorly correlated | +0.68% | ||
More |